Julian Higgins
#33,471
Most Influential Person Now
Statistician
Julian Higgins's AcademicInfluence.com Rankings
Julian Higginsmathematics Degrees
Mathematics
#2011
World Rank
#3174
Historical Rank
Statistics
#70
World Rank
#97
Historical Rank
Download Badge
Mathematics
Julian Higgins's Degrees
- PhD Statistics Stanford University
- Masters Mathematics University of California, Berkeley
- Bachelors Mathematics University of California, Berkeley
Similar Degrees You Can Earn
Why Is Julian Higgins Influential?
(Suggest an Edit or Addition)According to Wikipedia, Julian P. T. Higgins is a British biostatistician, Professor of Evidence Synthesis and Director of Research at the Department of Population Health Sciences at the University of Bristol. Higgins was previously Chair in Evidence Synthesis at the University of York, and Programme Leader at the MRC Biostatistics Unit in Cambridge. He is also a founding trustee and a Past-President of the Society for Research Synthesis Methodology.
Julian Higgins's Published Works
Published Works
- Measuring inconsistency in meta-analyses (2003) (44805)
- The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials (2011) (21564)
- Cochrane Handbook for Systematic Reviews of Interventions (2019) (17045)
- Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0. The Cochrane Collaboration (2013) (10433)
- RoB 2: a revised tool for assessing risk of bias in randomised trials (2019) (7746)
- Introduction to Meta‐Analysis (2009) (7363)
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions (2016) (7256)
- Chapter 8: Assessing risk of bias in included studies (2008) (4657)
- Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials (2011) (4355)
- Assessing Risk of Bias in Included Studies (2008) (4351)
- Chapter 9: Analysing Data and Undertaking Meta-Analyses (2008) (2885)
- Analysing data and undertaking meta‐analyses (2019) (2045)
- Interpretation of random effects meta-analyses (2011) (1834)
- A re-evaluation of random-effects meta-analysis (2009) (1695)
- Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. (2020) (1694)
- Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. (2019) (1661)
- Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis (2018) (1627)
- Graphical Tools for Network Meta-Analysis in STATA (2013) (1574)
- Tools for assessing quality and susceptibility to bias in observational studies in epidemiology: a systematic review and annotated bibliography. (2007) (1489)
- Meta-analyses involving cross-over trials: methodological issues. (2002) (1480)
- Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis (2009) (1479)
- Simultaneous comparison of multiple treatments: combining direct and indirect evidence (2005) (1410)
- A revised tool for assessing risk of bias in randomized trials (2016) (1230)
- Controlling the risk of spurious findings from meta‐regression (2004) (1102)
- Risk‐of‐bias VISualization (robvis): An R package and Shiny web app for visualizing risk‐of‐bias assessments (2020) (1043)
- GRADE guidelines: 7. Rating the quality of evidence--inconsistency. (2011) (1042)
- ROBIS: A new tool to assess risk of bias in systematic reviews was developed (2016) (981)
- Evaluation of networks of randomized trials (2008) (945)
- Chapter 16: Special Topics in Statistics (2008) (918)
- Basics of meta‐analysis: I2 is not an absolute measure of heterogeneity (2017) (917)
- Assessing risk of bias in a randomized trial (2019) (913)
- Evaluating the Quality of Evidence from a Network Meta-Analysis (2014) (847)
- Meta-Regression in Stata (2008) (815)
- Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression‡ (2012) (770)
- Conceptual and Technical Challenges in Network Meta-analysis (2013) (743)
- Methods to estimate the between‐study variance and its uncertainty in meta‐analysis† (2015) (743)
- Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified. (2008) (738)
- Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review (2006) (726)
- The Interpretation of Random-Effects Meta-Analysis in Decision Models (2005) (707)
- Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic Review (2008) (655)
- Predicting the extent of heterogeneity in meta-analysis, using empirical data from the Cochrane Database of Systematic Reviews (2012) (615)
- A systematic review of the use of opioids in the management of dyspnoea (2002) (596)
- Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials. (2008) (595)
- Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice (2002) (587)
- Borrowing strength from external trials in a meta-analysis. (1996) (560)
- Assessment of cumulative evidence on genetic associations: interim guidelines. (2008) (559)
- Choosing effect measures and computing estimates of effect (2019) (558)
- Recent developments in meta‐analysis (2008) (540)
- The Prevalence of Non-Alcoholic Fatty Liver Disease in Children and Adolescents: A Systematic Review and Meta-Analysis (2015) (533)
- Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data (2010) (523)
- Selecting Studies and Collecting Data (2008) (516)
- Application of Systematic Review Methodology to Food and Feed Safety Assessments to Support Decision Making (2010) (498)
- Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE statement (2009) (494)
- Systematic review of prevalence studies of autism spectrum disorders (2005) (484)
- STrengthening the REporting of Genetic Association Studies (STREGA)— An Extension of the STROBE Statement (2009) (482)
- Special Topics in Statistics (2008) (481)
- The Impact of Study Size on Meta-analyses: Examination of Underpowered Studies in Cochrane Reviews (2013) (474)
- Completing ‘Summary of findings’ tables and grading the certainty of the evidence (2019) (429)
- Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. (2006) (424)
- Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66 155 cases and 91 307 controls (2006) (417)
- Evaluation of inconsistency in networks of interventions. (2013) (400)
- Dietary fat intake and prevention of cardiovascular disease: systematic review (2001) (398)
- Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19: A Meta-analysis. (2021) (391)
- Living Systematic Reviews: An Emerging Opportunity to Narrow the Evidence-Practice Gap (2014) (391)
- Systematic review: Hygiene and health: systematic review of handwashing practices worldwide and update of health effects (2014) (388)
- CINeMA: An approach for assessing confidence in the results of a network meta-analysis (2020) (379)
- Systematic review: Assessing the impact of drinking water and sanitation on diarrhoeal disease in low‐ and middle‐income settings: systematic review and meta‐regression (2014) (375)
- CYP2C9 gene variants, drug dose, and bleeding risk in warfarin-treated patients: A HuGEnet™ systematic review and meta-analysis (2005) (374)
- Association of BCG, DTP, and measles containing vaccines with childhood mortality: systematic review (2016) (369)
- Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis (2017) (359)
- GRADE guidelines: 18. How ROBINS-I and other tools to assess risk of bias in nonrandomized studies should be used to rate the certainty of a body of evidence. (2018) (358)
- A comparison of heterogeneity variance estimators in simulated random‐effects meta‐analyses (2018) (357)
- Interpreting results and drawing conclusions (2019) (353)
- Meta-Analysis and Subgroups (2013) (348)
- Portion, package or tableware size for changing selection and consumption of food, alcohol and tobacco (2015) (344)
- A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation (2014) (333)
- Including Non‐Randomized Studies (2008) (321)
- Meta-analysis of skewed data: Combining results reported on log-transformed or raw scales (2008) (310)
- Characteristics of meta-analyses and their component studies in the Cochrane Database of Systematic Reviews: a cross-sectional, descriptive analysis (2011) (291)
- Assessing risk of bias due to missing results in a synthesis (2019) (275)
- Imputation methods for missing outcome data in meta-analysis of clinical trials (2008) (273)
- A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered. (2009) (271)
- Evaluation of the Cochrane Collaboration’s tool for assessing the risk of bias in randomized trials: focus groups, online survey, proposed recommendations and their implementation (2014) (269)
- Adjuvant chemotherapy for resected early-stage non-small cell lung cancer. (2015) (263)
- Revised Cochrane risk of bias tool for randomized trials (RoB 2.0): additional considerations for cluster-randomized trials (2016) (260)
- Lack of evidence for the efficacy of memantine in mild Alzheimer disease. (2011) (256)
- Safety and Effectiveness of Recombinant Human Bone Morphogenetic Protein-2 for Spinal Fusion (2013) (253)
- A road map for efficient and reliable human genome epidemiology (2006) (252)
- Impact of drinking water, sanitation and handwashing with soap on childhood diarrhoeal disease: updated meta‐analysis and meta‐regression (2018) (247)
- Predictive distributions were developed for the extent of heterogeneity in meta-analyses of continuous outcome data (2015) (247)
- Presenting Results and ‘Summary of Findings’ Tables (2008) (245)
- Statistical algorithms in Review Manager 5 (2010) (239)
- Association Between Risk-of-Bias Assessments and Results of Randomized Trials in Cochrane Reviews: The ROBES Meta-Epidemiologic Study (2017) (231)
- Sequential methods for random-effects meta-analysis (2010) (224)
- Predictive distributions for between-study heterogeneity and simple methods for their application in Bayesian meta-analysis (2014) (224)
- Array CGH in patients with learning disability (mental retardation) and congenital anomalies: updated systematic review and meta-analysis of 19 studies and 13,926 subjects (2009) (218)
- Synthesizing evidence on complex interventions: how meta-analytical, qualitative, and mixed-method approaches can contribute. (2013) (217)
- Personal financial incentives for changing habitual health-related behaviors: A systematic review and meta-analysis (2015) (215)
- Obstacles and opportunities in meta-analysis of genetic association studies (2005) (215)
- Reduced or modified dietary fat for preventing cardiovascular disease (2000) (212)
- The Association Between the Peroxisome Proliferator-Activated Receptor-γ2 (PPARG2) Pro12Ala Gene Variant and Type 2 Diabetes Mellitus: A HuGE Review and Meta-Analysis (2010) (212)
- A design-by-treatment interaction model for network meta-analysis with random inconsistency effects (2014) (207)
- Considerations in boosting COVID-19 vaccine immune responses (2021) (205)
- Fixed‐Effect Versus Random‐Effects Models (2009) (205)
- Opioids for the palliation of breathlessness in terminal illness. (2001) (204)
- Strengthening the Reporting of Observational Studies in Epidemiology Using Mendelian Randomization: The STROBE-MR Statement. (2021) (204)
- Can meta-analysis help target interventions at individuals most likely to benefit? (2005) (184)
- Empirical Evidence of Study Design Biases in Randomized Trials: Systematic Review of Meta-Epidemiological Studies (2016) (178)
- Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials: overview of published comments and analysis of user practice in Cochrane and non-Cochrane reviews (2016) (178)
- Systematic Reviews of Genetic Association Studies (2009) (176)
- Assessing risk of bias in a non‐randomized study (2019) (174)
- COVID-19 in Older People: A Rapid Clinical Review (2020) (173)
- Biases in Randomized Trials: A Conversation Between Trialists and Epidemiologists. (2017) (172)
- Considering bias and conflicts of interest among the included studies (2019) (167)
- Five Glutathione S-Transferase Gene Variants in 23,452 Cases of Lung Cancer and 30,397 Controls: Meta-Analysis of 130 Studies (2006) (159)
- Converting Among Effect Sizes (2009) (158)
- Assessing baseline imbalance in randomised trials: implications for the Cochrane risk of bias tool (2014) (155)
- Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis. (2017) (150)
- A re‐evaluation of fixed effect(s) meta‐analysis (2018) (149)
- Evidence for the Selective Reporting of Analyses and Discrepancies in Clinical Trials: A Systematic Review of Cohort Studies of Clinical Trials (2014) (149)
- Issues relating to study design and risk of bias when including non‐randomized studies in systematic reviews on the effects of interventions (2013) (147)
- Tools for assessing risk of reporting biases in studies and syntheses of studies: a systematic review (2018) (147)
- Glutathione S-transferase M1 (GSTM1) polymorphisms and lung cancer: a literature-based systematic HuGE review and meta-analysis. (2008) (147)
- Effect Sizes Based on Means (2009) (145)
- Genome-Wide Association Studies, Field Synopses, and the Development of the Knowledge Base on Genetic Variation and Human Diseases (2009) (144)
- Including variants on randomized trials (2019) (141)
- Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration (2021) (139)
- Including non‐randomized studies on intervention effects (2019) (138)
- Living Systematic Review (2021) (135)
- Risk of neuropsychiatric adverse events associated with varenicline: systematic review and meta-analysis (2015) (128)
- Cognitive-behavioural interventions for children who have been sexually abused. (2012) (127)
- Impact of blinding on estimated treatment effects in randomised clinical trials: meta-epidemiological study (2020) (127)
- How can the evaluation of genetic tests be enhanced? Lessons learned from the ACCE framework and evaluating genetic tests in the United Kingdom (2005) (126)
- CINeMA: Software for semiautomated assessment of the confidence in the results of network meta‐analysis (2020) (124)
- Being sceptical about meta-analyses: a Bayesian perspective on magnesium trials in myocardial infarction. (2002) (121)
- A network of investigator networks in human genome epidemiology. (2005) (121)
- HETEROGI: Stata module to quantify heterogeneity in a meta-analysis (2005) (121)
- Seven lipoprotein lipase gene polymorphisms, lipid fractions, and coronary disease: a HuGE association review and meta-analysis. (2008) (118)
- The Emergence of Networks in Human Genome Epidemiology: Challenges and Opportunities (2007) (112)
- Guide to the Contents of a Cochrane Protocol and Review (2008) (111)
- Checklists of methodological issues for review authors to consider when including non‐randomized studies in systematic reviews (2013) (107)
- When Does it Make Sense to Perform a Meta‐Analysis? (2009) (106)
- The impact of the COVID-19 pandemic on self-harm and suicidal behaviour: a living systematic review. (2020) (105)
- Methods to calculate uncertainty in the estimated overall effect size from a random‐effects meta‐analysis (2018) (105)
- Strengthening the reporting of genetic association studies (STREGA): an extension of the strengthening the reporting of observational studies in epidemiology (STROBE) statement. (2009) (105)
- STrengthening the REporting of Genetic Association studies (STREGA) – an extension of the STROBE statement (2009) (103)
- Dealing with effect size multiplicity in systematic reviews and meta‐analyses (2018) (102)
- Screening strategies for atrial fibrillation: a systematic review and cost-effectiveness analysis. (2017) (102)
- Synthesising quantitative evidence in systematic reviews of complex health interventions (2019) (101)
- Evaluating the Quality of Evidence from a Network Meta-Analysis. (2014) (100)
- An introduction to methodological issues when including non‐randomised studies in systematic reviews on the effects of interventions (2013) (99)
- Allowing for uncertainty due to missing data in meta‐analysis—Part 1: Two‐stage methods (2008) (99)
- Undertaking network meta‐analyses (2019) (97)
- A Cochrane Risk Of Bias AssessmentTool:forNon-RandomizedStudies of Interventions (ACROBAT-NRSI) (2014) (96)
- STROBE-MR: Guidelines for strengthening the reporting of Mendelian randomization studies (2019) (96)
- Interventions for treating hallux valgus (abductovalgus) and bunions. (2004) (96)
- Joint effects of the N-acetyltransferase 1 and 2 (NAT1 and NAT2) genes and smoking on bladder carcinogenesis: a literature-based systematic HuGE review and evidence synthesis. (2007) (95)
- Additional considerations are required when preparing a protocol for a systematic review with multiple interventions. (2017) (93)
- Systematic review of controlled trials on the effectiveness of fluoride gels for the prevention of dental caries in children. (2003) (91)
- Preparing a Cochrane review (2008) (91)
- Comparative Efficacy and Acceptability of 21 Antidepressant Drugs for the Acute Treatment of Adults With Major Depressive Disorder: A Systematic Review and Network Meta-Analysis. (2018) (91)
- Interventions for treating hallux valgus (abductovalgus) and bunions. (2009) (91)
- Estimating within-study covariances in multivariate meta-analysis with multiple outcomes (2012) (90)
- Multiple Outcomes or Time‐Points within a Study (2009) (89)
- Randomised controlled trial of novel, simple, and well supervised weight reducing diets in outpatients (1998) (88)
- Identifying and Quantifying Heterogeneity (2009) (88)
- Cognitive-behavioural interventions for children who have been sexually abused. (2007) (88)
- Risk of nosocomial respiratory syncytial virus infection and effectiveness of control measures to prevent transmission events: a systematic review (2016) (87)
- Corticosteroids in septic shock: a systematic review and network meta-analysis (2017) (87)
- Altering the availability or proximity of food, alcohol, and tobacco products to change their selection and consumption (2017) (86)
- Network meta-analysis: a norm for comparative effectiveness? (2015) (84)
- Comparative performance of heterogeneity variance estimators in meta‐analysis: a review of simulation studies (2016) (83)
- Genetic associations in peripheral joint osteoarthritis and spinal degenerative disease: a systematic review (2007) (81)
- A general framework for the use of logistic regression models in meta-analysis (2016) (80)
- Systematic review of controlled trials of interventions to promote smoke alarms (2000) (77)
- Systematic reviews and metaanalysis (1997) (77)
- Graphical augmentations to the funnel plot assess the impact of additional evidence on a meta-analysis. (2012) (75)
- Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis (2019) (74)
- Strengthening the reporting of genetic association studies (STREGA): an extension of the STROBE Statement (2009) (71)
- The impact of the COVID-19 pandemic on self-harm and suicidal behaviour: update of living systematic review (2021) (69)
- Bayesian multivariate meta‐analysis with multiple outcomes (2013) (68)
- Reporting of industry funded study outcome data: comparison of confidential and published data on the safety and effectiveness of rhBMP-2 for spinal fusion (2013) (68)
- Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis (2017) (67)
- Dietary advice given by a dietitian versus other health professional or self-help resources to reduce blood cholesterol. (2003) (67)
- The albatross plot: A novel graphical tool for presenting results of diversely reported studies in a systematic review (2017) (66)
- Choice of implant combinations in total hip replacement: systematic review and network meta-analysis (2017) (66)
- Investigating and dealing with publication bias and other reporting biases in meta‐analyses of health research: A review (2020) (65)
- METAREG: Stata module to perform meta-analysis regression (2004) (64)
- Allowing for uncertainty due to missing continuous outcome data in pairwise and network meta‐analysis (2015) (61)
- Disagreements in meta-analyses using outcomes measured on continuous or rating scales: observer agreement study (2009) (61)
- Non-invasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis (2012) (60)
- Planning future studies based on the conditional power of a meta-analysis (2012) (58)
- Expressing findings from meta‐analyses of continuous outcomes in terms of risks (2011) (58)
- Control of carbapenemase-producing Enterobacteriaceae outbreaks in acute settings: an evidence review. (2017) (56)
- Characteristics of a loop of evidence that affect detection and estimation of inconsistency: a simulation study (2014) (56)
- A tool to assess the quality of a meta‐analysis (2013) (56)
- Maintaining Reviews: Updates, Amendments and Feedback (2008) (53)
- Allowing for uncertainty due to missing data in meta‐analysis—Part 2: Hierarchical models (2008) (51)
- Starting a review (2019) (50)
- [ROBIS: a new tool to assess risk of bias in systematic reviews was developed.] (2018) (46)
- Cumulative Meta‐Analysis (2009) (46)
- Random‐Effects Model (2009) (44)
- Summarising and validating test accuracy results across multiple studies for use in clinical practice (2015) (43)
- Challenges in the use of literature-based meta-analysis to examine gene-environment interactions. (2010) (42)
- Fixed‐Effect Model (2009) (41)
- Assessing Confidence in the Results of Network Meta-Analysis (Cinema) (2019) (40)
- Comparative efficacy and safety of treatments for localised prostate cancer: an application of network meta-analysis (2014) (39)
- An empirical comparison of heterogeneity variance estimators in 12 894 meta‐analyses (2015) (39)
- The HuGENetTM HuGE Review Handbook, version 1.0 (2006) (39)
- Evaluating the impact of imputations for missing participant outcome data in a network meta-analysis (2013) (37)
- Dietary advice given by a dietitian versus other health professional or self-help resources to reduce blood cholesterol. (2003) (37)
- Applicability and Feasibility of Systematic Review for Performing Evidence-Based Risk Assessment in Food and Feed Safety (2015) (37)
- Bayesian synthesis of epidemiological evidence with different combinations of exposure groups: application to a gene–gene–environment interaction (2006) (37)
- Multiplicity of data in trial reports and the reliability of meta-analyses: empirical study (2011) (37)
- Bayesian meta‐analysis and meta‐regression for gene–disease associations and deviations from Hardy–Weinberg equilibrium (2007) (36)
- Effect Sizes Based on Correlations (2009) (36)
- Machine learning to assist risk-of-bias assessments in systematic reviews (2015) (35)
- Implementing informative priors for heterogeneity in meta‐analysis using meta‐regression and pseudo data (2016) (34)
- Heterogeneity in application, design, and analysis characteristics was found for controlled before-after and interrupted time series studies included in Cochrane reviews. (2017) (34)
- Relative efficacy of differential methods of dietary advice: a systematic review. (2003) (33)
- Extending DerSimonian and Laird's methodology to perform network meta‐analyses with random inconsistency effects (2015) (33)
- Empirical evidence about inconsistency among studies in a pair‐wise meta‐analysis (2015) (33)
- Impact of placebo arms on outcomes in antidepressant trials: systematic review and meta-regression analysis (2018) (32)
- Meta‐analysis of genetic association studies under different inheritance models using data reported as merged genotypes (2008) (31)
- Rethinking the assessment of risk of bias due to selective reporting: a cross-sectional study (2016) (31)
- Network meta‐analysis of rare events using the Mantel‐Haenszel method (2019) (30)
- B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data (2018) (30)
- Criticisms of Meta‐Analysis (2009) (29)
- Multiple Comparisons within a Study (2009) (28)
- Corticosteroid therapy for critically ill patients with COVID-19: A structured summary of a study protocol for a prospective meta-analysis of randomized trials (2020) (27)
- How a Meta‐Analysis Works (2009) (26)
- Triangulating Evidence through the Inclusion of Genetically Informed Designs. (2020) (26)
- Home visiting for socially disadvantaged mothers (2010) (26)
- Management of the clinically positive neck in organ preservation for advanced head and neck cancer. (1998) (26)
- Meta-analysis in occupational epidemiology: a review of practice. (2004) (26)
- Levonorgestrel-releasing (20 microgram/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives. (2000) (26)
- Evidence-Based Prescribing: Combining Network Meta-Analysis With Multicriteria Decision Analysis to Choose Among Multiple Drugs (2014) (25)
- Reduced or modified dietary fat for preventing cardiovascular disease. (2001) (25)
- Array-based comparative genomic hybridization for investigating chromosomal abnormalities in patients with learning disability: Systematic review meta-analysis of diagnostic and false-positive yields (2007) (24)
- Treatment interventions to maintain abstinence from alcohol in primary care: systematic review and network meta-analysis (2020) (24)
- Sample size calculation for meta‐epidemiological studies (2016) (23)
- Effectiveness and cost-effectiveness of serum B-type natriuretic peptide testing and monitoring in patients with heart failure in primary and secondary care: an evidence synthesis, cohort study and cost-effectiveness model. (2017) (23)
- Human Genome Epidemiology ( HuGE ) Review Glutathione S-Transferase M 1 ( GSTM 1 ) Polymorphisms and Lung Cancer : A Literature-based Systematic HuGE Review and Meta-Analysis (2008) (23)
- Updated systematic review: associations between proximity to animal feeding operations and health of individuals in nearby communities (2017) (23)
- Health‐related lifestyle in adults and children with primary immune thrombocytopenia (ITP) (2010) (23)
- Turning the pump handle: evolving methods for integrating the evidence on gene-disease association. (2007) (23)
- WITHDRAWN: Opioids for the palliation of breathlessness in advanced disease and terminal illness. (2012) (23)
- Between-trial heterogeneity in meta-analyses may be partially explained by reported design characteristics (2017) (23)
- Two-stage meta-analysis of survival data from individual participants using percentile ratios (2012) (22)
- Antidepressants might work for people with major depression: where do we go from here? (2018) (21)
- MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Systematic Review (2021) (20)
- Allowing for Informative Missingness in Aggregate Data Meta-Analysis with Continuous or Binary Outcomes: Extensions to Metamiss (2018) (20)
- Meta‐Analysis Methods Based on Direction and p‐Values (2009) (20)
- The impact of the COVID-19 pandemic on self-harm and suicidal behaviour: protocol for a living systematic review (2020) (19)
- STrengthening the REporting of Genetic Association studies (STREGA): an extension of the STROBE Statement. (2009) (19)
- Power Analysis for Meta‐Analysis (2009) (19)
- Developing the WCRF International/University of Bristol Methodology for Identifying and Carrying Out Systematic Reviews of Mechanisms of Exposure–Cancer Associations (2017) (19)
- Independent Subgroups within a Study (2009) (19)
- Effect Sizes Based on Binary Data (2×2 Tables) (2009) (18)
- CHAPTER 7 Converting Among Effect Sizes (2013) (18)
- Response to paper by Lang A, Edwards N, and Fleiszer A. (2007) (17)
- Accounting for heterogeneity in meta‐analysis using a multiplicative model—an empirical study (2017) (17)
- Prospective approaches to accumulating evidence (2019) (17)
- Meta-analysis with Missing Data (2009) (17)
- Vote Counting – A New Name for an Old Problem (2009) (17)
- Generality of the Basic Inverse‐Variance Method (2009) (17)
- Notes on Subgroup Analyses and Meta‐Regression (2009) (17)
- The choice between hip prosthetic bearing surfaces in total hip replacement: a protocol for a systematic review and network meta-analysis (2016) (16)
- Online genetic databases informing human genome epidemiology (2007) (16)
- Methodological features of clinical pharmacokinetic-pharmacodynamic studies of antibacterials and antifungals: a systematic review. (2020) (15)
- Omega‐3 fatty acids for prevention of cardiovascular disease (2001) (14)
- Systematic review with meta‐analysis: the gastrointestinal benefits of COX‐2 selective inhibitors with concomitant use of low‐dose aspirin (2016) (14)
- Altering the availability or proximity of food, alcohol, and tobacco products to change their selection and consumption. (2019) (14)
- Detecting heterogeneity of intervention effects using analysis and meta-analysis of differences in variance between arms of a trial (2020) (13)
- ROBIS: Tool to Assess Risk of Bias in Systematic Reviews (2019) (13)
- Cognitive‐behavioural interventions for sexually abused children (1999) (13)
- Chapter 22 : Prospective approaches to accumulating evidence (2019) (13)
- Suicide and self-harm in low- and middle- income countries during the COVID-19 pandemic: A systematic review (2021) (13)
- Ten questions to consider when interpreting results of a meta‐epidemiological study—the MetaBLIND study as a case (2019) (13)
- The REPRISE project: protocol for an evaluation of REProducibility and Replicability In Syntheses of Evidence (2021) (13)
- Tenets for the Proper Conduct and Use of Meta-Analyses: A Practical Guide for Neurosurgeons. (2022) (13)
- MELODI: Mining Enriched Literature Objects to Derive Intermediates (2017) (12)
- WITHDRAWN: Interventions for treating hallux valgus (abductovalgus) and bunions. (2009) (12)
- Protocol for a systematic review and individual participant data meta-analysis of B-type natriuretic peptide-guided therapy for heart failure (2014) (12)
- Systematic reviews in health research (2019) (12)
- Presenting random effects meta-analyses: where we are going wrong? (2001) (12)
- The Use of Bayesian Networks to Assess the Quality of Evidence from Research Synthesis: 1. (2015) (12)
- Risk of Bias 2 in Cochrane Reviews: a phased approach for the introduction of new methodology. (2020) (12)
- Data Mining in Clinical Trial Text: Transformers for Classification and Question Answering Tasks (2020) (12)
- Reporting of Systematic Reviews: The Challenge of Genetic Association Studies (2007) (12)
- Convincing evidence from controlled and uncontrolled studies on the lipid-lowering effect of a statin. (2012) (11)
- Data extraction methods for systematic review (semi)automation: A living systematic review (2021) (11)
- The impact of trial characteristics on premature discontinuation of antipsychotics in schizophrenia (2013) (11)
- Detecting Heterogeneity of Intervention Effects Using Analysis and Meta-analysis of Differences in Variance Between Trial Arms (2021) (11)
- Altering the availability or proximity of food, alcohol, and tobacco products to change their selection and consumption (2019) (11)
- The INVEST project: investigating the use of evidence synthesis in the design and analysis of clinical trials (2017) (11)
- ROB-MEN: a tool to assess risk of bias due to missing evidence in network meta-analysis (2021) (11)
- The median and the mode as robust meta‐analysis estimators in the presence of small‐study effects and outliers (2020) (11)
- Systematic review of the impact of the COVID-19 pandemic on suicidal behaviour amongst health and social care workers across the world (2021) (10)
- Data extraction methods for systematic review (semi)automation: A living review protocol (2020) (10)
- Prognostic value of test(s) for O6 -methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide (2019) (10)
- The Use of Bayesian Networks to Assess the Quality of Evidence from Research Synthesis: 2. Inter-Rater Reliability and Comparison with Standard GRADE Assessment (2015) (9)
- Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis (2018) (9)
- CHAPTER 13 Fixed-Effect Versus Random-Effects Models (9)
- Identifying and addressing inconsistency in network meta-analysis (2013) (9)
- Prevalence of BRAFV600 in glioma and use of BRAF Inhibitors in patients with BRAFV600 mutation-positive glioma: systematic review (2021) (8)
- Therapeutic interventions for alcohol dependence in non-inpatient settings: a systematic review and network meta-analysis (protocol) (2017) (8)
- Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta‐analysis (2020) (7)
- Label‐invariant models for the analysis of meta‐epidemiological data (2017) (7)
- Directly Acting Oral Anticoagulants for the Prevention of Stroke in Atrial Fibrillation in England and Wales: Cost-Effectiveness Model and Value of Information Analysis (2019) (7)
- Investigating the transparency of reporting in two-sample summary data Mendelian randomization studies using the MR-Base platform (2021) (7)
- Adjusting trial results for biases in meta‐analysis: combining data‐based evidence on bias with detailed trial assessment (2019) (7)
- Why Perform a Meta‐Analysis (2009) (6)
- Assessing the Credibility of Findings From Nonrandomized Studies of Interventions. (2018) (6)
- Selection bias introduced by informative censoring in studies examining effects of vaccination in infancy. (2019) (6)
- Doug Altman's legacy to Cochrane and evidence synthesis. (2018) (6)
- Rate-Constrained Ranking and the Rate-Weighted AUC (2014) (5)
- Diagnostic test accuracy and cost-effectiveness of tests for codeletion of chromosomal arms 1p and 19q in people with glioma (2019) (5)
- Indirect evidence of reporting biases was found in a survey of medical research studies. (2017) (5)
- The association between proximity to animal-feeding operations and community health: a protocol for updating a systematic review (2014) (5)
- Guidance to detect, evaluate and prevent the problem of selective reporting in trial publications (2013) (5)
- review systematic cardiovascular disease, and cancer: Risks and benefits of omega 3 fats for mortality, (2006) (5)
- Prognostic value of test(s) for O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation for predicting overall survival in people with glioblastoma treated with temozolomide. (2021) (5)
- Assessment of systematic effects of methodological characteristics on candidate genetic associations (2013) (5)
- Comments on ‘Empirical vs natural weighting in random effects meta‐analysis’ (2010) (4)
- Reporting the Results of a Meta‐Analysis (2009) (4)
- Examining how meta‐analytic methods perform in the presence of bias: A simulation study (2021) (4)
- Recovery from chronic fatigue syndrome: a systematic review—heterogeneity of definition limits study comparison (2021) (4)
- Does testosterone mediate the relationship between vitamin D and prostate cancer? A systematic review and meta-analysis protocol (2019) (4)
- Poor systematic reviews and meta-analyses may be misleading (1998) (4)
- Notes on Complex Data Structures (2009) (4)
- Prevalence of evidence of inconsistency and its association with network structural characteristics in 201 published networks of interventions (2021) (4)
- Human genome epidemiology: The road map revisited (2010) (4)
- BAYESIAN META-ANALYSIS (2019) (4)
- The impact of the COVID-19 pandemic on self-harm and suicidal behaviour: a living systematic review [version 1; peer review: 1 approved] (2020) (4)
- Computing Effect Sizes for Meta-analysis (2020) (3)
- Further Methods for Dichotomous Data (2009) (3)
- Psychometric Meta‐Analysis (2009) (3)
- Effect Sizes Rather than p‐Values (2009) (3)
- MGMT promoter methylation testing to predict overall survival in people with glioblastoma treated with temozolomide: a comprehensive meta-analysis based on a Cochrane Systematic Review. (2021) (3)
- The range of peripapillary retinal nerve fibre layer and optic disc parameters, in children aged up to but not including 18 years of age who were born prematurely: protocol for a systematic review (2016) (3)
- Factors that Affect Precision (2009) (3)
- Tools for the assessment of quality and risk of bias in Mendelian randomization studies: a systematic review (2021) (3)
- Making the best use of available evidence: the case of new generation antidepressants (2009) (2)
- 14:00 MULTIPLE-TREATMENTS META-ANALYSIS ON THE EFFICACY, ACCEPTABILITY AND TOLERABILITY OF 15 ANTIPSYCHOTICS DRUGS IN SCHIZOPHRENIA (2012) (2)
- A Conversation Between Trialists and Epidemiologists (2)
- Network Meta-Analysis of Oral Anticoagulants for Primary Prevention, Treatment and Secondary Prevention of Venous Thromboembolic Disease, and for Prevention of Stroke in Atrial Fibrillation. (2015) (2)
- CINeMA: Software for semi-automated assessment of the Confidence In the results of Network Meta-Analysis (2019) (2)
- The range of peripapillary retinal nerve fibre layer and optic disc parameters in children aged up to but not including 18 years of age, as measured by optical coherence tomography: protocol for a systematic review (2016) (2)
- Does milk intake promote prostate cancer initiation or progression via effects on insulin-like growth factors (IGFs)? A systematic review and meta-analysis (2017) (2)
- A new large-scale meta-epidemiological study on bias in randomized trials using routinely collected risk-of-bias assessments by cochrane reviewers: results from the robes study (2015) (2)
- Anti-oxidant foods or supplements for preventing cardiovascular disease (Protocol for a Cochrane Review) (2003) (2)
- The Cost-Effectiveness Of Novel Oral Anticoagulants For The Prevention Of Stroke In Atrial Fibrillation In England And Wales. (2015) (2)
- The impact of the COVID-19 pandemic on self-harm and suicidal behaviour: a living systematic review [version 1; peer review: 1 approved, 2 approved with reservations] (2021) (2)
- 69 Inclusion of both patient level and study-level covariates in a meta-analysis (1997) (2)
- Books, Web Sites and Professional Organizations (2009) (1)
- Choice between implants in knee replacement: protocol for a Bayesian network meta-analysis, analysis of joint registries and economic decision model to determine the effectiveness and cost-effectiveness of knee implants for NHS patients—The KNee Implant Prostheses Study (KNIPS) (2020) (1)
- Pre-emptive versus non pre-emptive kidney transplantation for end-stage kidney disease (2018) (1)
- Lethal Injection: Other Views (2007) (1)
- Practice of Epidemiology Challenges in the Use of Literature-based Meta-Analysis to Examine Gene-Environment Interactions (2010) (1)
- New cochrane risk of bias tool for cluster randomised tools (2017) (1)
- Heath-related lifestyle in adults and children with primary immune thrombocytopenia (ITP): Correspondence (2010) (1)
- Comprar General and Applied Toxicology | Dr Julian P.T Higgins | 9780470723272 | Wiley (2009) (1)
- Tool to assess risk of bias due to missing evidence in network meta-analysis (ROB-MEN): elaboration and examples (2021) (1)
- Worked Examples (Part 2) (2009) (1)
- Confounders and co-interventions identified in non-randomized studies of interventions. (2022) (1)
- The impact of the COVID-19 pandemic on self-harm and suicidal behaviour: a living systematic review [version 1; peer review: awaiting peer review] (2020) (1)
- Additional file 2: of The range of peripapillary retinal nerve fibre layer and optic disc parameters in children aged up to but not including 18Â years of age, as measured by optical coherence tomography: protocol for a systematic review (2016) (0)
- Prevalence of Inconsistency and Its Association With Network Structural Characteristics in 201 Published Networks of Interventions (2021) (0)
- Additional file 3: of B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data (2018) (0)
- Title: Systematic review with meta-analysis: the gastrointestinal benefit of COX-2 selective inhibitors with concomitant use of low-dose aspirin Running title: Coxib gastrointestinal benefit with aspirin use (2016) (0)
- Methods for meta-analysis of the diagnostic test accuracy studies (2017) (0)
- Simpson's Paradox (2009) (0)
- Screening strategies for atrial fibrillation (2017) (0)
- Could Reducing Body Fatness Reduce the Risk of Aggressive Prostate Cancer via the Insulin Signalling Pathway? A Systematic Review of the Mechanistic Pathway (2021) (0)
- Assessment of systematic effects of methodological characteristics on candidate genetic associations (2012) (0)
- The Prevalence of BRAF Mutations in Patients with Glioma: A Systematic Review (2019) (0)
- An alternative to testing for heterogeneity in a meta-analysis (2001) (0)
- METAMISS: Stata module to perform meta-analysis with missing data (2008) (0)
- Clinical results (1): stroke prevention in atrial fibrillation (2017) (0)
- Reported design characteristics influence heterogeneity among randomized trials (2017) (0)
- Authors’ response to comments from Nachman KE et al. (2017) (0)
- metamiss: Meta-analysis with missing data (2007) (0)
- B-type natriuretic peptide-guided therapy for heart failure (HF) (2018) (0)
- British Medical Journal (1904) (0)
- B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data. Systematic (2018) (0)
- Use of external evidence for design and Bayesian analysis of clinical trials: a qualitative study of trialists’ views (2021) (0)
- Agreement was moderate between data-based and opinion-based assessments of biases affecting randomized trials within meta-analyses (2020) (0)
- Title Neuraminidase antibodies and H 5 N 1 : Geographic-dependent influenza epidemiology could determine cross-protection against emerging strains (2007) (0)
- Evaluation of the use of array arative genomic hybridisation diagnosis of learning disability (2006) (0)
- Prevalence of BRAF V600 in primary gliomas: a systematic review (2021) (0)
- Identifying and triangulating all available evidence on the effect of blood lipids and statins on dementia outcomes (2021) (0)
- Authors' response to letter to the editor (2017) (0)
- THE CHOICE BETWEEN HIP PROSTHETIC IMPLANTS IN TOTAL HIP ARTHROPLASTY: A COST-EFFECTIVENESS MODEL USING UK AND SWEDISH HIP JOINT REGISTRIES DATA (2018) (0)
- Development of a method for adjusting trial results for biases in meta-analysis (2013) (0)
- The Stata Journal (2010) (0)
- STREGA Reporting Recommendations, Extended from STROBE Statement (2009) (0)
- PRM2 - Evidence-based prescribing : using existing data on benefits and harms to choose among multiple drugs (2014) (0)
- A Cost-Effectiveness Analysis of Novel Oral Anticoagulants for Primary Prevention of Venous Thromboembolic Disease. (2015) (0)
- Scope for meta-analysis of gene-environment interactions using published data: the case of PPARγ gene (2009) (0)
- A novel approach to understanding outcome selection and reporting during the evaluation of innovative surgery from first in human to pragmatic RCT: an evolution review (2015) (0)
- Challenging Nature of Evidence-Based Decision Making (2014) (0)
- Syddansk Universitet Evaluation of the Cochrane tool for assessing risk of bias in randomized clinical trials overview of published comments and analysis of user practice in Cochrane and non-Cochrane (2016) (0)
- Worked Examples (Part 1) (2009) (0)
- Systematic Review And Meta-Analysis of Accuracy of Diagnostic Tests For Screen Detection of Atrial Fibrillation (2016) (0)
- comp in the Re Evaluation of the use of array arative genomic hybridisation diagnosis of learning disability port of a UK Genetic Testing Network Working Party (2006) (0)
- The Choice Between HIP Prosthetic Implants in Total HIP Replacement: A Systematic Review and Network Meta-Analysis (2016) (0)
- Cost-effectiveness planes: base-case economic evaluation (2017) (0)
- P117 Statistical issues in the meta-analysis of treatments for Alzheimer's disease (1997) (0)
- (2019). Design characteristics, risk of bias, and reporting of randomised controlled trials supporting European Medicines Agency approvals of cancer drugs, 2014-2016: Cross-sectional analysis. BMJ , 366 (2019) (0)
- Effectiveness of BRAF inhibitors in patients with BRAF V600 mutation positive glioma: a systematic review (2019) (0)
- A Cost-Effectiveness Analysis Of Novel Oral Anticoagulants For Acute Treatment And Secondary Prevention Of Venous Thromboembolic Disease. (2015) (0)
- Integration of the evidence on gene-disease associations: Methods of HuGE reviews (2010) (0)
- Cost-Effectiveness Analysis of Screening Strategies for Atrial Fibrillation in England and Wales (2016) (0)
This paper list is powered by the following services:
Other Resources About Julian Higgins
What Schools Are Affiliated With Julian Higgins?
Julian Higgins is affiliated with the following schools: